Advances in treating acute myeloid leukemia

Margaret M. Showel, Mark Levis

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Acute myeloid leukemia (AML) arises within the bone marrow from a malignant hematopoietic progenitor cell. Though AML is still often fatal, cure rates overall continue to improve incrementally yet steadily, primarily for two reasons: first, insights into the pathogenesis of AML over the last several decades have led to the development of a relatively sophisticated classification scheme that allows more nuanced risk stratification to guide treatment choices; second, improvements in stem cell transplantation have allowed many more patients to take advantage of this highly effective therapeutic technique. Improvements in overall survival for patients with AML are expected to continue rising because of the anticipated introduction of targeted therapies into this treatment platform.

Original languageEnglish (US)
Article number96
JournalF1000Prime Reports
StatePublished - Oct 1 2014

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Advances in treating acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this